Verastem (VSTM) Common Equity (2011 - 2026)

Verastem's Common Equity history runs 16 years deep, the most recent figure standing at $81.8 million for Q1 2026.

• In Q1 2026, Common Equity rose 352.14% year-over-year to $81.8 million; the TTM figure through Mar 2026 stood at $81.8 million (up 352.14% YoY), while the FY2025 annual figure was $57.2 million, up 297.96% from the prior year.
• Common Equity was $81.8 million for Q1 2026 at Verastem, up from $57.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $101.6 million in Q2 2023 to a low of -$32.4 million in Q1 2025.
• Historically, Common Equity has averaged $39.1 million across 5 years, with a median of $47.4 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Common Equity plunged 240.38% in 2025, then soared 352.14% in 2026.
• A 5-year view of Common Equity shows it stood at $47.4 million in 2022, then advanced by 21.07% to $57.4 million in 2023, then sank by 150.36% to -$28.9 million in 2024, then jumped by 297.96% to $57.2 million in 2025, then surged by 42.97% to $81.8 million in 2026.
• The last three Common Equity figures came in at $81.8 million (Q1 2026), $57.2 million (Q4 2025), and -$15.5 million (Q3 2025), per Business Quant data.